Previous close | 11.09 |
Open | 11.03 |
Bid | 10.83 x 1400 |
Ask | 10.87 x 1200 |
Day's range | 10.61 - 11.20 |
52-week range | 8.75 - 95.34 |
Volume | |
Avg. volume | 7,016,749 |
Market cap | 925.694M |
Beta (5Y monthly) | 1.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | -17.51 |
Earnings date | 27 Feb 2023 - 03 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 55.33 |
Novavax (NVAX) closed the most recent trading day at $11.09, moving -1.25% from the previous trading session.
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.